Vinayak Doraiswamy, Chief Scientific Officer at AtriCure, Inc. (ATRC), sold 9,966 shares at $45.99 ($458K) on 2022-09-15, disclosed to the SEC on 2022-09-19.
Open-market sale of $458k ATRC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.99 | 4,983 | $229K | 50.0% |
| 2 | $45.99 | 4,983 | $229K | 50.0% |
| Total | $45.99 avg | 9,966 | $458K | 100% |
| Filing → |
| ATRC | SELL | 2026-03-16 | $149K | — | Filing → |
| ATRC | SELL | 2025-08-07 | $91K | — | Filing → |
| ATRC | SELL | 2025-05-30 | $84K | — | Filing → |